AAX Biotech

Stockholm, Sweden · Founded 2020 · Privately Held (backing)

Developer of antibody technologies intended for cancer, autoimmune diseases, and neurological diseases. AAX Biotech is based in Stockholm, Sweden and was founded in 2020. Its last reported valuation was $4.1 million in Oct 2024. It has raised $1.2 million.

Last reported valuation

$4.1M

Oct 2026

Priced at

—

Total raised

$1.2M

Last round

—

How much has AAX Biotech raised?

$1.2Macross 0 recorded rounds

Free account

More of AAX Biotech with a free account

·The complete investor list: 12 names
·Watch AAX Biotech: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

AAX Biotech investors

12 investors are on record for AAX Biotech, including Jinderman & Partners, DRIVE ( KI Innovations Business Incubator), HJKK Didrikson and Karolinska Institutet.

For fundraisers

Raising for a company like AAX Biotech?

12 investors have backed AAX Biotech.

See all 12 investors →

Frequently asked about AAX Biotech

How much has AAX Biotech raised?: AAX Biotech has raised $1.2M in total across 0 recorded funding rounds.